Pharmaceutical Headlines for 24 may 2011 ( Tuesday ) !

• Valeant Pharmaceuticals International (VRX) in $446 Million Deal for Generics Firm More...

• Johnson & Johnson (JNJ) to Buy JB Chemicals & Pharmaceuticals Limited's Russian Brands for About $260 Million More..

.

• Shire plc in $2 Billion Bid for Cubist Pharmaceuticals, Inc. (CBST); Shire May Face Competition From Other Suitors More...

• Prometheus Laboratories Inc. Announces Agreement to be Acquired by Nestle Health Science More...

• Sigma-Aldrich Corporation (SIAL) Acquires Vetec Quimica Fina Ltd More..

.

• Permanent Headcount Down to Nil at Antisoma Inc. (ASM.L) More...

• Radius Announces Closing of $91 Million Financing to Advance BA058 Injection into Phase 3 Osteoporosis Study More...

• TetraLogic Pharmaceuticals Closes $6 Million Series C-1 Investment withNextech Invest Ltd. More...

• Accelerator Corporation Finances Twelfth Startup with Oncofactor Corporation More...

• AstraZeneca PLC (AZN) Gets Japan Boost with Cancer Drug Deal, Will Co-Promote Denosumab With Daiichi Sankyo, Inc. (D4S.F) More..

.

• 23andMe, Inc. Brings Down the Price of Consumer Genetic Tests, Builds Up Relations With Big Pharma More...

• Vanguard EMS and Tektronix Component Solutions Establish Joint Marketing Agreement More...

• Centella Therapeutics Licenses Novel New Drug Designed to Enhance the Effectiveness of Cancer Treatment More...

• Xcellerex, Inc. and Gallus Biopharmaceuticals, LLC Announce Biomanufacturing Collaboration More..

• Oragenics, Inc. (ONI) Announces New President, Chief Executive Officer More...

• RainDance Technologies Names Andy Watson Vice President and Chief Marketing Officer More...

• Jim Mitchell Promoted to Chief Operating Officer of Yulex Corporation More...

• NuPathe Inc. Strengthens Commercial Team More...

• Oxford BioMedica PLC (OXB.L) Management and Board Changes More...

• Skystar Bio-Pharmaceutical (CGPN) Reports First Quarter 2011 Results More...

• Abbott Laboratories (ABT) Sued on Claims Humira Caused Permanent Eye Damage More...

• Vertex Pharmaceuticals (MA) (VRTX)'s Big Success Boosts Boston's $800 Million Fan Pier Project More...

• Analab Clinical Research Announces Opening of New Phase I/II Facility More...

• On the Opening of the Biomed Israel 2011 Week: President Peres Has Announced the Launch of a Brain Research International Center in Israel More...

• Biologics Process Development, Inc. to Double the Size of its Bioprocess Laboratory More...

• AstraZeneca PLC (AZN), Biogen Idec, Inc. (Massachusetts) (BIIB) Look Elsewhere for Drug Candidates More...

• Taro Pharmaceutical Industries Ltd. (TARO) Receives FDA Approval for Cetirizine Hydrochloride Oral Solution, 1 mg/mL (Sugar Free Bubble Gum Flavor) More...

• Provectus Pharmaceuticals Inc. Completes Patient Accrual in Phase 2C Clinical Trial of PH-10 for Psoriasis More...

• KemPharm, Inc. Announces Positive Results from Phase 1 Trial of KP201 for Pain More...

• Data From a Phase 1 Clinical Trial of Exelixis, Inc. (EXEL)'s Cabozantinib Published in the Journal of Clinical Oncology More...

• Pre-Meal Dietary Supplement Developed at Hebrew University Can Overcome Fat and Sugar Problems, Hebrew University of Jerusalem Reveals More...

• Natural Product Shows Pain-Killing Properties, The Scripps Research Institute Study Finds More...

• Certain COPD Meds Linked to Urinary Troubles in Men, St. Michael's Hospital Study More...

• Heart Scientists Discover Protein that May be 1 Cause of Heart Failure,University Health Network Study More...

• Researchers Demonstrate Mechanism Behind Compound’s Effects on Skin Inflammation and Cancer Progression, Brigham and Women's Hospital Study More...

Posted in: Daily,Pharma Hub